Phase I Open-Label Randomized Multicenter Study of XNW28012 Monotherapy in Metastatic Pancreatic Cancer
Clinical trial NCT07707674 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07707674
- Sponsor
- Evopoint Biosciences Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-30
- Primary completion
- 2028-04-30
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.